QR Code

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients

Background/Aim: A reduction in portal vein inflow velocity seems to predispose to the emergence of portal vein thrombosis (PVT). Nonselective β-blockers (NSBBs), used to prevent variceal bleeding, may increase the development of PVT by reducing portal vein inflow velocity. In this retrospective case...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Rosa Zampino, Rita Lebano, Nicola Coppola, Margherita Macera, Anna Grandone, Luca Rinaldi, Ilario De Sio, Antonella Tufano, Gianfranca Stornaiuolo, Luigi E Adinolfi, Emanuele Durante-Mangoni, Gaeta G Battista, Alferio Niglio
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wolters Kluwer Medknow Publications 2018-01-01
Rangatū:The Saudi Journal of Gastroenterology
Ngā marau:
Cirrhosis
nonselective beta blockers
portal vein thrombosis
Urunga tuihono:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2018;volume=24;issue=1;spage=25;epage=29;aulast=Zampino
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite